Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: Changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
Prediction of antibody persistency from antibody titres to natalizumab.
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
Multiple sclerosis: Monotherapy rules.
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
[A different approach to the care of patients with MS].
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Low body weight linked to PML risk with natalizumab in MS
Risk of fractures in patients with multiple sclerosis: record-linkage study.
Gait and six-minute walk performance in persons with multiple sclerosis.
Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Laminar cortical damage in multiple sclerosis.
Sleep loss as risk factor for neurologic disorders: A review.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
Multiple Sclerosis from Bench to Bedside.
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
Pages
« first
‹ previous
…
295
296
297
298
299
300
301
302
303
…
next ›
last »